Class Action Lawsuit Filed Against Chemours Co (NYSE:CC)
Oct 22, 2026
Chemours Co faces a securities class action lawsuit alleging fraud over overstated Opteon product demand and unreliable 2026 financial guidance. Investors are being encouraged to seek recovery for losses incurred during the specified period.
ACCESS Newswire
Show all 134 updates